StemCell Institute Revenue

StemCell Institute had revenue of 729.00M JPY in the quarter ending December 31, 2025, with 9.30% growth. This brings the company's revenue in the last twelve months to 2.78B, up 5.54% year-over-year. In the fiscal year ending March 31, 2025, StemCell Institute had annual revenue of 2.68B with 7.98% growth.

Revenue (ttm)

2.78B

Revenue Growth

+5.54%

P/S Ratio

3.19

Revenue / Employee

23.79M

Employees

117

Market Cap

8.87B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	2.68B	198.00M	7.98%
Mar 31, 2024	2.48B	390.00M	18.65%
Mar 31, 2023	2.09B	310.00M	17.41%
Mar 31, 2022	1.78B	372.00M	26.40%
Mar 31, 2021	1.41B	-267.00M	-15.93%
Mar 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Mar 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Mar 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Linical	9.32B
CellSource	3.71B
MEDINET	998.00M
OncoTherapy Science	784.00M
PRISM BioLab Co.,LTD	684.61M
Chiome Bioscience	593.29M
Carna Biosciences	579.06M
CellSeed	161.00M

Revenue Rankings